Maynard Um
-
-
-
-
-
-
-
Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald on FDA Approval
-
-
-
-
-
-
-
FDA Approves Hepcludex injection to treat chronic Hepatitis Delta virus infection in adults w/o Cirrhosis or w/ compensated Cirrhosis
-
-
-
-
-
-
-
Stocks expected to have increasing option volume: GILD OPEN SYNA ARLO HUBS FROG SG WEN FIS MXK MELI MCHP RILY RNG QCOM SERV LOCO YELP REAL IREN GSAT MSI
-
-
-
-
-
-
-
Gilead exercises option for Kymera's cancer drug candidate KT-200
-
-
-
-
-
-
-
Gilead Sciences to acquire Tubulis for up to $5 billion
-
-
-
-
-
-
-
Bernstein on Gilead Sciences (GILD) Amid Ouro Acquisition
-
-
-
-
-
-
-
Jefferies Starts Vertex (VRTX) at Buy
-
422,375 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

